KMO
Basic information
Region (hg38): 1:241532134-241595642
Links
Phenotypes
GenCC
Source:
- pellagra (No Known Disease Relationship), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KMO gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 16 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 16 | 4 | 3 |
Variants in KMO
This is a list of pathogenic ClinVar variants found in the KMO region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-241532458-T-C | not specified | Uncertain significance (Dec 16, 2023) | ||
1-241532484-A-G | not specified | Uncertain significance (Sep 01, 2021) | ||
1-241548893-G-C | not specified | Uncertain significance (Mar 07, 2024) | ||
1-241560748-C-G | not specified | Uncertain significance (Aug 16, 2022) | ||
1-241562207-G-T | not specified | Uncertain significance (May 21, 2024) | ||
1-241562297-TACATGGAGTTGACTATTCC-T | Uncertain significance (Feb 08, 2023) | |||
1-241562315-C-T | Benign (Jun 01, 2018) | |||
1-241564987-T-C | not specified | Uncertain significance (Dec 31, 2023) | ||
1-241565006-A-G | not specified | Uncertain significance (Dec 20, 2023) | ||
1-241566504-C-T | KMO-related disorder | Likely benign (Nov 09, 2022) | ||
1-241566515-T-C | not specified | Uncertain significance (Jan 19, 2024) | ||
1-241566563-G-A | not specified | Likely benign (Jun 19, 2024) | ||
1-241566588-C-T | Likely benign (Jun 01, 2018) | |||
1-241566589-G-A | Benign (Aug 28, 2018) | |||
1-241568552-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
1-241568588-G-C | not specified | Uncertain significance (Jan 24, 2024) | ||
1-241568622-C-T | not specified | Uncertain significance (Apr 22, 2022) | ||
1-241568656-T-A | Benign (Aug 28, 2018) | |||
1-241588810-T-C | not specified | Uncertain significance (Jun 07, 2024) | ||
1-241588826-T-C | not specified | Uncertain significance (Sep 25, 2023) | ||
1-241590214-C-G | not specified | Uncertain significance (Oct 13, 2021) | ||
1-241590241-A-G | not specified | Uncertain significance (Dec 19, 2022) | ||
1-241591963-A-G | not specified | Uncertain significance (Nov 18, 2022) | ||
1-241592013-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
1-241592023-A-G | not specified | Uncertain significance (Jan 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KMO | protein_coding | protein_coding | ENST00000366559 | 15 | 63511 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000478 | 0.999 | 125671 | 0 | 67 | 125738 | 0.000266 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.83 | 180 | 263 | 0.683 | 0.0000129 | 3218 |
Missense in Polyphen | 55 | 92.729 | 0.59313 | 1131 | ||
Synonymous | -1.40 | 107 | 90.1 | 1.19 | 0.00000465 | 880 |
Loss of Function | 2.79 | 12 | 27.9 | 0.431 | 0.00000142 | 334 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00171 | 0.00169 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000546 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000203 | 0.000202 |
Middle Eastern | 0.0000546 | 0.0000544 |
South Asian | 0.000426 | 0.000425 |
Other | 0.000166 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the hydroxylation of L-kynurenine (L-Kyn) to form 3-hydroxy-L-kynurenine (L-3OHKyn) (PubMed:29429898, PubMed:23575632, PubMed:26752518, PubMed:28604669, PubMed:29208702). Required for synthesis of quinolinic acid, a neurotoxic NMDA receptor antagonist and potential endogenous inhibitor of NMDA receptor signaling in axonal targeting, synaptogenesis and apoptosis during brain development. Quinolinic acid may also affect NMDA receptor signaling in pancreatic beta cells, osteoblasts, myocardial cells, and the gastrointestinal tract (Probable). {ECO:0000269|PubMed:23575632, ECO:0000269|PubMed:26752518, ECO:0000269|PubMed:28604669, ECO:0000269|PubMed:29208702, ECO:0000269|PubMed:29429898, ECO:0000305|PubMed:12402501}.;
- Pathway
- Tryptophan metabolism - Homo sapiens (human);Tryptophan Metabolism;Selenium Micronutrient Network;NAD Biosynthesis II (from tryptophan);Tryptophan catabolism;Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;Metabolism of amino acids and derivatives;tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde;Metabolism;L-kynurenine degradation;Tryptophan metabolism;NAD <i>de novo</i> biosynthesis;Tryptophan degradation;superpathway of tryptophan utilization;tryptophan degradation
(Consensus)
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- loftool
- 0.708
- rvis_EVS
- 0.66
- rvis_percentile_EVS
- 84.55
Haploinsufficiency Scores
- pHI
- 0.0692
- hipred
- N
- hipred_score
- 0.475
- ghis
- 0.402
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.613
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Kmo
- Phenotype
- homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- kmo
- Affected structure
- podocyte
- Phenotype tag
- abnormal
- Phenotype quality
- morphology
Gene ontology
- Biological process
- tryptophan catabolic process;aging;response to salt stress;NAD metabolic process;quinolinate biosynthetic process;kynurenic acid biosynthetic process;'de novo' NAD biosynthetic process from tryptophan;anthranilate metabolic process;oxidation-reduction process;kynurenine metabolic process;cellular response to lipopolysaccharide;cellular response to interleukin-1;L-kynurenine metabolic process;positive regulation of neuron death;positive regulation of glutamate secretion, neurotransmission
- Cellular component
- extracellular space;mitochondrion;mitochondrial outer membrane;cytosol;integral component of membrane
- Molecular function
- kynurenine 3-monooxygenase activity;NAD(P)H oxidase activity;flavin adenine dinucleotide binding;FAD binding